BRANDON ALAN GUENTHART, MD

Plain English
This study looked at two ways to monitor heart transplant patients for rejection: using a combination of gene expression profiling and biopsies versus a newer method that relies on analyzing donor-derived cell-free DNA. Researchers found that after three years, both groups had similar survival rates (around 86%) and other health measures, but those using the DNA method had significantly fewer biopsies needed (4 compared to 12). This is important because it means patients can be monitored for rejection without undergoing as many invasive procedures. Who this helps: Heart transplant patients can benefit from less invasive monitoring while still maintaining good health outcomes.

Plain English
This study looked at a new method of heart transplantation called beating heart transplantation (BHT) and compared its results to standard heart transplants from donors after circulatory death (DCD) in the U.S. Among 1,083 standard DCD recipients and 31 BHT recipients, those who received BHT had a similar survival rate 30 days after surgery (100% compared to 98.3%) but showed significantly better 1-year heart graft survival (100% vs. 83.9%). This matters because it indicates that even patients with more severe conditions pre-transplant can have good outcomes with this new approach. Who this helps: This helps patients with severe heart conditions needing a transplant.

Plain English
This study looked at a new way to perform heart transplants using beating heart implantation and a method called ex-vivo heart perfusion. Out of 24 patients who received transplants, 95.8% were still alive after about 192 days, and most showed no signs of heart rejection. This matters because it shows that this technique can successfully use hearts from donors who died from circulatory death, leading to better patient outcomes. Who this helps: Patients needing heart transplants.

Plain English
This study looked at heart transplant outcomes for patients aged 70 and older in the U.S. from 2006 to 2022. It found that 87.5% of patients aged 70 or older survived for one year after their transplant, which is lower than the 91.1% survival rate for those under 60 but has improved from 80.7% in the earlier decade. This is important because it shows that older patients can have good outcomes with heart transplants, suggesting they should be considered for these procedures more often. Who this helps: This helps older patients who need a heart transplant.

Plain English
This study looked at how extracorporeal membrane oxygenation (ECMO) is used to help patients with multiple organ failures who are waiting for a transplant. Out of nearly 4,000 patients who had thoracic multiorgan transplants from 1987 to 2022, 203 used ECMO as a support system, primarily for heart-lung transplants. The findings showed that while patients on ECMO had higher death rates within the first 30 days after the transplant, those who survived past that point had similar long-term survival rates compared to those who did not use ECMO. Who this helps: This information benefits doctors and healthcare providers managing patients with severe organ failure awaiting transplants.

Plain English
This study examined the views of primary care providers (PCPs) on lung cancer screening programs. Out of 58 PCPs surveyed, 63.8% preferred using these programs for decision-making visits, while 70.7% favored them for deciding next steps after a positive CT scan. The findings indicate that while PCPs see the benefits of these programs, such as saving time and providing specialized care, nearly half raised concerns about the extra visit and costs for patients. Who this helps: This helps patients at risk for lung cancer by improving their access to specialized screening services.

Plain English
This study looked at the relationship between a serious complication called chylothorax and how aggressively lymph nodes are removed during lung cancer surgery. Among 1,728 patients, only 1.9% developed chylothorax, but those who did were more likely to have had extensive lymph node removal and experienced longer hospital stays and higher rates of needing further surgeries. This is important because it highlights the risks of aggressive lymph node management and suggests that surgery could be done more carefully, especially for smaller tumors. Who this helps: This research helps patients undergoing lung surgery and their doctors by informing surgical decisions.

Plain English
This study looked at how different levels of blood thinning medication (anticoagulation) during a treatment called venovenous ECMO affect bleeding and clotting issues in severely ill patients. Out of 26 patients, major bleeding happened in 1 of 12 (8.3%) in the low-intensity group and 4 of 14 (28.6%) in the moderate-intensity group, suggesting that lower intensity may reduce serious bleeding risks. Given that no patients died in the low-intensity group compared to 2 in the moderate group who experienced major bleeding, this matters because it could offer a safer option for patients needing ECMO support. Who this helps: Patients undergoing venovenous ECMO treatment.

Plain English
This study focused on creating a new simulation model to help train surgeons in a specific procedure called esophagogastric anastomosis, which is an important part of esophagectomy surgery. The model, which uses a robotic system and mimics real anatomy, received high ratings from participants for its realism and educational value, with scores around 4.8 out of 5 for several aspects. This matters because it provides a safe training environment for surgeons to improve their skills before performing sensitive surgeries on real patients. Who this helps: This benefits trainee surgeons and ultimately improves care for patients undergoing esophagectomy.

Plain English
This study looked at a new method called ex-vivo lung perfusion to help with the shortage of donor lungs for transplantation. Researchers successfully used this technique on a single donor lung that might have been rejected, allowing it to be transplanted. As a result, more patients can potentially receive lung transplants, which is critical given the high rejection rates of donor lungs. Who this helps: This helps patients in need of lung transplants.

Plain English
This study looked at the effectiveness of PET scans in staging a specific type of lung cancer called subsolid lung adenocarcinoma. The researchers found that while PET scans correctly identified lymph node involvement 95.1% of the time (high specificity), they missed detecting it in 80% of the cases (low sensitivity). Additionally, the use of PET scans did not improve the chances of staying cancer-free for five years compared to those who did not have the scan. Who this helps: This information benefits doctors treating patients with early-stage subsolid lung adenocarcinoma.

Plain English
This study looked at how much people in the community know about lung cancer screening. Of 214 people surveyed, 71% didn’t know there was a screening method for lung cancer, but many said they would be willing to get screened if eligible. This matters because increasing awareness can lead to more people getting screened, which may help detect lung cancer earlier and save lives. Who this helps: This helps patients at risk for lung cancer by promoting important screening options.

Plain English
This study examined lung cancer patients who had surgery to remove a lung, comparing those who underwent minimally invasive techniques with those who had traditional surgery. They found that 5-year survival rates were similar: about 48% for minimally invasive surgery versus 45% for open surgery. However, when minimally invasive surgery had to be switched to traditional surgery, there was a slight increase in the risk of death. Who this helps: Patients undergoing lung cancer surgery.

Plain English
Researchers studied how a biodegradable thin film could improve blood flow to airways in rats that had undergone lung transplants. They found that the film significantly enhanced blood supply in the transplanted airways, improving blood flow metrics at three different time points—0, 3, and 10 days—compared to those without the film. This matters because better blood flow can help reduce complications and improve survival rates after lung transplants. Who this helps: This helps lung transplant patients by potentially reducing airway complications.

Plain English
This study looked at how preserving blood flow from the bronchial arteries during a process called ex-vivo lung perfusion (EVLP) affects the health of transplanted lungs. Researchers found that when they included bronchial artery perfusion, there was a significant increase in blood flow to the airways and less damage to the airway tissues. Specifically, airway tissues showed significantly less cell death and better overall structure compared to lungs that only received blood from the pulmonary artery. Who this helps: This research benefits lung transplant patients by potentially reducing early complications that can arise after surgery.

Plain English
This paper corrects earlier research about using a method called ex vivo lung perfusion (a way to treat lungs outside the body) in children’s lungs for adult patients. The study showed that this method may increase the chances of successful lung transplants. This matters because it could improve outcomes for adults needing lung transplants from pediatric donors. Who this helps: This helps patients awaiting lung transplants.

Plain English
This study looked at how well DOTATATE-PET scans can detect whether carcinoid tumors in the lungs have spread to nearby lymph nodes before surgery. Out of 58 patients, only 3 lymph node involvements were correctly identified by the scan, resulting in a low sensitivity rate of 20%, and making it clear that the scan is not very reliable for this purpose. The findings highlight the need for thorough examination of lymph nodes during surgery, despite what the DOTATATE-PET results show. Who this helps: Patients with lung carcinoid tumors and their surgeons.

Plain English
This study looked at lung transplants from donors whose hearts had stopped beating (known as donation after circulatory death, or DCD) between 2017 and 2022. It found that patients receiving lungs from DCD donors had a higher chance of dying within a year after the transplant, with a mortality rate of 13.9% compared to 10.7% for those receiving lungs from brain-dead donors. Certain factors like being over 65 years old, needing intensive care, having poor kidney function, and the lung being outside the body for more than 7 hours also increased the risk of death. Who this helps: This information benefits doctors making decisions about lung transplants and helps identify high-risk patients.

Plain English
This study focused on creating a detailed simulation model for surgeons to practice a type of lung surgery called lobectomy using robotic assistance. Researchers found that 100% of seasoned faculty rated the simulation model highly, with trainees reporting improved confidence levels after practice sessions—from a score of 2.5 to 3.9. This matters because it provides an effective training tool that can help new surgeons gain necessary skills and confidence before performing real surgeries. Who this helps: This helps surgical trainees and educators in medical programs.

Plain English
This study looked at how to improve damaged donor lungs so they can be used for transplants. Researchers tested various methods on 23 lungs, including 17 that were injured, to develop a new approach combining therapy and diagnosis, which they called "theranostic." They found that using certain treatments allowed for real-time monitoring and improvements in lung function, with a focus on enhancing the viability of donor lungs that would otherwise be discarded. Who this helps: This benefits patients needing lung transplants and the doctors who provide their care.

Plain English
This research looked at a new way to perform heart transplants that doesn’t require a specific step called cardioplegic arrest, which has traditionally been necessary. The authors found that using this new method could help preserve donated hearts more effectively, potentially allowing more hearts to be used for transplants. This matters because it could lead to more successful heart transplants and better outcomes for patients waiting for a new heart. Who this helps: Patients needing heart transplants.

Plain English
This study focused on a new method for heart transplantation using hearts from donors whose hearts stopped beating (called DCD donors). The researchers created a technique that allows the heart to keep beating during the transplant process, which can reduce damage typically caused by cooling the heart. They believe this approach could lead to better recovery and longer-lasting results, similar to those seen in heart transplants from brain-dead donors. Who this helps: This benefits heart transplant patients by potentially improving their transplant outcomes.

Plain English
Researchers developed a new robotic device that helps surgeons assess the stiffness of soft tissues during minimally invasive surgeries, making it easier to identify issues like tumors. In tests with tissues from pigs and rats, the device accurately measured tissue stiffness, successfully locating a tumor mimic that was 2 cm wide and 5 mm deep. This advancement is important because it allows surgeons to make better decisions during surgery, improving patient outcomes. Who this helps: This helps patients undergoing robotic surgery.

Plain English
Researchers studied a new type of sealant designed to fix lung air leaks, a common problem after lung surgery that affects up to 60% of patients. This new "lung-mimetic" hydrofoam sealant closely resembles lung tissue, allowing it to effectively seal air leaks in lab animal tests, restoring normal lung function. These findings are important because they provide a potential solution for a complication that traditionally lacks reliable treatment. Who this helps: This benefits patients recovering from lung surgery.

Plain English
This study looked at heart-lung transplants performed at a single medical center over the last 40 years, analyzing the survival rates of 271 patients. It found that patients who received transplants more recently (after 2001) had much better survival rates compared to those who received them earlier: 30-day survival improved from 84% to 97%, 1-year survival from 77% to 89%, and 10-year survival from 26% to 53%. This matters because it shows that advancements in medical techniques and care have significantly increased the chances of living longer after a heart-lung transplant. Who this helps: Heart-lung transplant patients and their doctors.

Plain English
This study looked at a new way to transplant hearts from donors who died from circulatory failure, known as the "beating heart" method. Researchers treated 10 men with severe heart failure and found that all patients survived and none required additional support like the extracorporeal membrane oxygenation (ECMO) machine after surgery. This is significant because it shows that this method can safely improve outcomes for heart transplants from these donors. Who this helps: This benefits patients with severe heart failure who might receive a heart from a donor after circulatory death.

Plain English
This study looked at why some patients eligible for low-dose CT scans for lung cancer screening do not complete the procedure. Out of 380 patients, 331 (87%) went through with the scan while 49 (13%) did not. The findings showed that many patients underestimated their risk of lung cancer and expressed little interest in re-scheduling the scan, which highlights the need for better education and motivation for patients at risk. Who this helps: This helps patients at risk for lung cancer and healthcare providers involved in their care.

Plain English
This study examined how different types of thoracic surgery affect muscle atrophy in the abdominal area. Researchers found that patients who underwent robotic thoracic surgery experienced 31.4% muscle loss on the side of the surgery, while those who had open surgery experienced only 9.5% loss, and those with video-assisted surgery had 14.1% loss. This is important because greater muscle atrophy can lead to complications and affect recovery, so understanding these differences can help improve surgical practices. Who this helps: This helps patients undergoing thoracic surgery and their doctors to make informed choices about surgical methods.

Plain English
This study looked at a new method to recover damaged donor lungs using a technique called cross-circulation with pigs that had lung injury. They found that after 24 hours of cross-circulation, the injured donor lungs showed a significant improvement in function, with oxygen levels increasing from 138 to 539 mm Hg. This is important because it could help address the shortage of healthy lungs for transplantation by allowing damaged lungs to be repaired before they are transplanted. Who this helps: This helps patients waiting for lung transplants.

Plain English
This study looked at patients who had surgery for esophageal cancer and found that nearly half of the leaks from their surgical connections went undetected on the initial imaging test, known as an esophagram. Out of 384 patients, 55 developed leaks, and 27 of them (49%) had normal results on their initial esophagram, which can lead to complications like unplanned hospital readmissions and additional surgeries. This matters because it shows that a normal test result doesn't always mean everything is fine, and doctors need to stay alert for possible issues even if the initial imaging looks good. Who this helps: This helps patients recovering from esophageal surgery and their doctors.

Plain English
This study examined a new method to find and measure air leaks in the lungs after surgery by using sounds made when air escapes from damaged tissue. Researchers tested this technique in both rats and pigs and found that the sounds from air leaks can reveal how severe the leak is and where it is located, with an accuracy of about 1 centimeter. This method could help doctors better detect and treat lung air leaks during surgery, potentially improving patient outcomes. Who this helps: This helps patients undergoing lung surgery and their doctors.

Plain English
This research studied how to treat tracheal stenosis, a narrowing of the trachea, in patients who had severe COVID-19 and were intubated. Eight female patients with tracheal stenosis were treated, with 62.5% undergoing surgery to remove and reconstruct part of the trachea, and 80% of those patients were symptom-free six months later. The findings suggest that managing tracheal stenosis after COVID-19 is effective, and there are also less invasive options for those who might not be good candidates for surgery. Who this helps: This benefits patients recovering from severe COVID-19 who develop airway complications.

Plain English
This study looked at how a treatment called hyperthermic intrathoracic chemotherapy (HITHOC) affects survival in patients with pleural mesothelioma, a rare and serious cancer. Researchers analyzed data from 3,232 patients, finding that those who received HITHOC lived longer on average—about 20.5 months compared to 16.8 months for those who didn't get the treatment. Although patients who underwent HITHOC had longer hospital stays and higher readmission rates, they also had lower chances of dying within 30 or 90 days after surgery. Who this helps: This benefits patients with pleural mesothelioma seeking better treatment outcomes.

Plain English
This study examined the risk of developing new lung cancer after breast cancer patients received radiation therapy (RT) over a period of 30 years. Among over 612,000 patients, 52% received RT, and 1.74% of those developed lung cancer, compared to 1.68% of patients who did not receive RT. The findings show that while there's a slightly increased risk of lung cancer for those who received RT, the overall risk is lower than previously thought, which is valuable information for doctors when advising and monitoring breast cancer patients. Who this helps: This helps breast cancer patients and their doctors.

Plain English
This study looked at the rates of in-hospital death after serious complications following lung cancer surgery in younger patients (under 80) compared to older patients (80 and over). The research found that 5.6% of younger patients died after complications, while the rate was higher at 12.0% for older patients, showing that older age increases the risk of failing to recover from complications. The study highlights that having surgery performed by a thoracic specialist can lower this risk for elderly patients, which is important for improving their chances of survival after surgery. Who this helps: This helps elderly patients and their families as well as doctors who perform lung cancer surgeries.

Plain English
This study looked at a new technique called xenogeneic cross-circulation, which uses pigs to support and improve human donor lungs that weren’t initially suitable for transplant. After 24 hours of using this technique on nine lungs, researchers found that lung function improved significantly; oxygen exchange increased by 158% and lung compliance went up by 127%. This method is important because it could help make more donor lungs available for patients in need of transplants by ensuring they remain healthy and functional before surgery. Who this helps: This benefits patients waiting for lung transplants.

Plain English
This study looked at the treatment of a serious condition called Stanford Type A aortic dissection, which occurred alongside a heart valve infection and bleeding in the brain. The researchers found that successful surgical repair was possible even in complex cases involving multiple health issues. This is important because it shows how teamwork among different medical specialists is crucial for effectively treating patients who are critically ill with various connected problems. Who this helps: This helps patients facing severe cardiovascular issues along with other health complications.

Plain English
This study explored how to effectively remove the damaged cells from the lining of rat trachea (the windpipe) and then evenly distribute new cells using a special gel. The results showed that the new cells were placed uniformly and could survive well in the trachea. This approach is important because it could lead to better ways to create treatments for serious lung conditions like cystic fibrosis and chronic obstructive pulmonary disease. Who this helps: Patients with lung diseases.

Plain English
Researchers developed a special device called a bioreactor that allows them to grow artificial airway tissue in the lab while also using imaging technology to see what’s happening inside the tissue as it's being produced. They successfully used this bioreactor to safely remove natural cells from rat trachea and then replace them with other cells while keeping the tissue structure intact. This advancement is important because it shows a new way to create functional airway tissues that could be used for drug testing or to replace damaged tissues in patients. Who this helps: This helps patients with chronic lung diseases and doctors looking for better treatment options.

Plain English
This study looked at the changes in the lung structure of patients with end-stage cystic fibrosis, focusing on the distal (far) part of the lungs, which hasn't been studied much before. Researchers found 68 proteins in the lung matrix that were expressed differently in cystic fibrosis patients, with over 90% of these proteins showing lower levels than in healthy lungs. This is important because it suggests that while the total amount of lung matrix remains the same, the diversity of proteins is reduced, which could impact lung health and point towards new treatments that not only fix the defective protein in cystic fibrosis but also improve the lung's structure. Who this helps: Patients with cystic fibrosis.

Plain English
This study looked at a patient with a rare and large cancerous tumor called an epithelioid hemangioendothelioma that formed in the major vein called the superior vena cava. The doctors successfully removed the tumor and repaired the vein, ensuring that no cancer cells were left behind. This is important because it shows that complex surgeries can be performed on these rare tumors, potentially leading to better outcomes for patients. Who this helps: This helps patients with rare vascular tumors and their doctors.

Plain English
This study describes the first successful case of a combined lung and kidney transplant in a patient who had COVID-19. The patient had severe organ damage from the virus, which is becoming more common among those infected. The findings show that lung transplants, either alone or with other organ transplants, are possible and could be life-saving for some patients with serious complications from COVID-19. Who this helps: This helps patients suffering from severe lung and kidney damage due to COVID-19.

Plain English
This study looked at a new way to measure how stiff lung tissue is without damaging it. Researchers found that the stiffness of lung tissue from rats increased by at least 64% when certain cells were disrupted, suggesting that lung stiffness changes in different conditions. This method is important because understanding lung stiffness can improve how we diagnose and treat lung diseases. Who this helps: This helps patients with lung conditions and doctors treating them.

Plain English
This study looked at a new method for preserving hearts during transportation for transplant, especially for patients who are hard to treat. The researchers successfully used a preservation system that kept a donor heart safe for 330 minutes, which is longer than the previous limit of 240 minutes. The patient, a 68-year-old woman, did well after her surgery and showed no signs of rejection three months later, indicating this method could help more people receive heart transplants. Who this helps: This helps patients in need of heart transplants, especially those with limited donor options.